Rs1625579 polymorphism in the MIR137 gene is associated with the risk of schizophrenia: updated meta-analysis

Neurosci Lett. 2019 Nov 20:713:134535. doi: 10.1016/j.neulet.2019.134535. Epub 2019 Oct 3.

Abstract

The Schizophrenia Psychiatric GWAS Consortium (PGC) has identified the rs1625579 polymorphism in the MIR137 gene, which encodes miR-137, as the strongest new association with schizophrenia in the European population. However, whether the influence of rs1625579 on schizophrenia in the Asian population is consistent with these results remains unclear. A total of 21 studies (9878 schizophrenic patients and 9447 control subjects) that met the inclusion criteria were included in our meta-analysis. Pooled analysis, subgroup analysis, sensitivity analysis and publication bias were performed. The T allele, TT genotype and TT + GG genotype were associated with schizophrenia as risk factors. Subgroup analysis shows that no heterogeneity existed in the European and Asian populations. Our meta-analysis found that the Rs1625579 polymorphism in the MIR137 gene was associated with the risk of schizophrenia. The current findings provide a reference for case-control studies of schizophrenia in the future.

Keywords: MIR137; Meta-analysis; Rs1625579; Schizophrenia.

Publication types

  • Meta-Analysis

MeSH terms

  • Adult
  • Alleles
  • Asian People / genetics
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics
  • Schizophrenia / genetics*
  • White People / genetics
  • Young Adult

Substances

  • MIRN137 microRNA, human
  • MicroRNAs